Bios Fund II QP, LP

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2025-05-27	2025-05-27	Lantern Pharma Inc. (LTRN)	PrS Proposed sale	65,232 301.69 US$2,480,747	65,232	301.69	US$2,480,747
2024-04-26	2024-04-29	Lantern Pharma Inc. (LTRN)	PrS Proposed sale	57,743 479.74 US$3,361,381	57,743	479.74	US$3,361,381
2024-02-28	2024-02-27	Lantern Pharma Inc. (LTRN)	PrS Proposed sale	84,800 416.65 US$3,764,442	84,800	416.65	US$3,764,442